BRAINSTORM CELL THERAPEUTICS (BCLI) Stock Balance Sheet
NASDAQ:BCLI • US10501E3009
Current stock price
1.17 USD
-0.03 (-2.5%)
At close:
0.67 USD
-0.5 (-42.74%)
After Hours:
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.64M | 187.00K | 1.30M | 770.00K | 18.86M | |||
| Marketable Securities | N/A | N/A | 0.00 | 2.21M | 3.24M | |||
| Receivables | 67.00K | 63.00K | 51.00K | 90.00K | 90.00K | |||
| Other Current Assets | 621.00K | 135.00K | 548.00K | 30.00K | 1.10M | |||
| Total Current Assets | 2.33M | 385.00K | 1.90M | 3.11M | 23.28M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.03M | 1.24M | 2.10M | 5.32M | 5.97M | |||
| Other Non-Current Assets | 204.00K | 206.00K | 207.00K | 20.00K | 30.00K | |||
| Total Non-Current Assets | 1.24M | 1.45M | 2.31M | 5.34M | 6.00M | |||
| TOTAL ASSETS | 3.57M | 1.83M | 4.21M | 8.45M | 29.28M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 981.00K | 1.17M | 1.84M | 1.51M | 1.54M | |||
| Accounts Payable | 6.80M | 6.08M | 4.95M | 6.22M | 3.70M | |||
| Other Current Liabilities | 1.92M | 1.73M | 1.00M | 1.07M | 1.07M | |||
| Total Current Liabilities | 10.90M | 8.98M | 7.80M | 8.80M | 6.32M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 127.00K | 618.00K | 1.27M | 2.67M | 3.62M | |||
| Total Non-Current Liabilities | 127.00K | 618.00K | 1.27M | 2.67M | 3.62M | |||
| TOTAL LIABILITIES | 11.03M | 9.60M | 9.07M | 11.47M | 9.94M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -229.50M | -226.64M | -215.01M | -197.82M | -173.54M | |||
| Additional Paid In Capital | 222.14M | 218.97M | 210.26M | 194.91M | 192.99M | |||
| Common Shares | 15.00K | 14.00K | 13.00K | 10.00K | 10.00K | |||
| Treasury Stock | -116.00K | -116.00K | -116.00K | -120.00K | -120.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 7.91M | 6.14M | 4.03M | 36.69M | 36.40M | |||
| Tangible Book Value per Share | -0.94 | -1.26 | -1.20 | -0.08 | 0.53 | |||
| Total Shareholders' Equity | -7.46M | -7.76M | -4.86M | -3.02M | 19.34M | |||
| TOTAL LIABILITIES AND EQUITY | 3.57M | 1.83M | 4.21M | 8.45M | 29.28M | |||
| Statistics | ||||||||
| Current Ratio | 0.21 | 0.04 | 0.24 | 0.35 | 3.68 | |||
| Return On Assets (ROA) | -310.45% | -634.44% | -408.56% | -287.34% | -83.54% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -126.47% | |||
All data in USD , ROIC based on taxRate of 0.21